Multiple Endocrine Neoplasia: Clinical Trials

2 trials for Multiple Endocrine Neoplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Multiple Endocrine Neoplasia: new trials by email Literature Review of Multiple Endocrine Neoplasia trials Research Report on Multiple Endocrine Neoplasia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Ribociclib, letrozole - Breast Cancer
Phase 3TerminatedNovartis Pharmaceuticals82017-06-072020-05-28
Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis
Timed intercourse, Microsurgical varicocelectomy, Intrauterine insemination - Pregnancy, Infertility
Phase 3TerminatedYale University32010-05-012013-07-02

Narrower conditions

Multiple Endocrine Neoplasia Type 1 (2)  ·  Breast Neoplasms (1)  ·  Infertility (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Multiple Primary (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Breast Diseases (1)  ·  Genital Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Urogenital Diseases (1)

Interventions

Letrozole (1)  ·  Surgical Procedures, Operative (1)  ·  ribociclib (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Yale University (1)

Countries

United States (2)

Top investigators

Christos Coutifaris, MD (1)  ·  Dana A Ohl, MD (1)  ·  Esther Eisenberg, MD, MPH (1)  ·  Gregory M Christman, MD (1)  ·  Heping Zhang, PhD (1)  ·  Michael Diamond, MD (1)  ·  Nanette Santoro, MD (1)  ·  Peter Casson, MD (1)  ·  Richard Legro, MD (1)  ·  Robert Brzyski, MD, PhD (1)  ·  William D Schlaff, MD (1)

Results publications

PMID 22130101

NIH funding

U10HD055925 (1), U10HD055936 (1)